Professional Documents
Culture Documents
Rise of
Commodity
Prices
Good Monsoon
Indian Firms
Deleveraging
Fast
We think that initial signs of recovery in earnings have started, but we have to wait for full recovery. According to one
estimates, Nifty 50 companies (so far available for 13 companies ) aggregate net sales and net profit grew 4% and
19% Y-o-Y respectively. As initial signs are positive, but full conclusion can only be drawn at the end of this month
when all results will be out. We expect consolidation phase as markets have run significantly in anticipation.
Tjho
pg
Ipqf
Issue Theme
Pg. 1
Company Analysis
Pg. 12-15
OPEN
FUNDAMENTAL
CALLS
Open Fundamental
Calls Pg. 16-17
www.jhaveritrade.com
Compatible with
All
A Operating Systems
Easy to Operate
Live Chart
Trade in EQUITY
FUTURE / OPTION
Live Price
Movement
08049336177
Call : 9925420000
www.jhaveritrade.com | www.jetrade.in
SMS JeTrade to : 9601336677
No Hidden
Charges
Kamlesh Jhaveri ( MD )
Jhaveri Securities Ltd.
www.jhaveritrade.com
Tjho
pg
Ipqf
Signs of Hope
Issue Theme
2010
2011
2012
2013
2014
2015
% Departure
1.6
-7.1
5.6
-11.9
-14
Conclusion
The domestic equity market showed a smart bounce throughout March, surging as much as 10% which revived hope of a
resumption of the last bull run that ended in March 2015. We are neither in a euphoric zone and nor in overvalued zone. One
of the most noticeable thing of current phase of market is new IPOs and new listings. New companies need to come because
when new companies come in to the market, they bring excitement. The near term big worry for the market is British Exit from
European Union. We believe that current phase of market is consolidation as market has discounted some recovery in
earnings and good hope of monsoon.
www.jhaveritrade.com
60
50
40
30
20
10
0
Revenue of Indian
Pharmaceutical Sector
( US$ Billion )
55
30
Generic Drugs
OTC Medicines
Patented Drugs
21%
6
2005
12
2013
2015
70%
2020E
www.jhaveritrade.com
Sector Update
The global pharmaceutical market is estimated to reach US$ 1.3 trillion by 2018, growing at a CAGR of 4-7% (between 2014
and 2018), an increase of US$ 290-320 billion. The growth of developed markets will be driven by the US, Japan and five
major European markets (Germany, France, Italy, Spain and the UK). The contribution of pharmerging markets in the growth
pie is expected to increase over the next five years; and account for nearly 50% of absolute growth in 2018.
The key growth drivers for the global pharmaceutical industry are the following:
Rising share of emerging economies in global GDP
Sector Update
Formulation Manufacturers
The growth story of the domestic formulations market is expected to remain strong, led by a rise in life-related diseases,
better healthcare diagnostic infrastructure adding to increasing disease detection rate, new product introductions, volume
growth driven by increasing penetration, and better access to healthcare. Domestic formulation sales are set to grow at a
CAGR of 12-14% between 2013-14 and 2018-19, with the market size crossing USD 20 billion.
Biotechnology Companies
The Indian Biotechnology sector is presently divided into five segments based on the products and services offered. These
segments are Bio-Pharmaceuticals, Bio-Services, Bio-Agriculture, Bio-Industrial and Bio-Informatics. Bio-Pharma is the
largest sector contributing to 62% of the total revenue followed by Bio-Services, Bio-Agri and Bio-Industrial sectors which
contribute 18%, 15% and 4% respectively. Bio-Informatics is still at a nascent stage contributing to only 1% of the total
revenue.
India is among the top 12 biotech destinations in the world and ranks second in Asia, after China. The Indian biotechnology
industry has evolved over the last three decades and the sector's revenue has rapidly increased from USD 300 million in
2002-03 to USD 4 billion in 2013-14.
www.jhaveritrade.com
India is the world's largest provider of generic medicines; the country's generic drugs account for 20% of global generic
drug exports.
In terms of Value, exports of pharmaceutical products increased at a CAGR of 26.1% to USD 10.1 billion during FY06-13.
The Americas accounted for around 34% of Indian Pharma exports in FY13,followed by Europe (26%) and Asia (20%)
Exports to Africa increased at a CAGR of 21% from FY09 to FY13,contributed mainly by export of anti-malarial and antiretroviral drugs.
12
10
10
3
2
0.4
0.6
0.7
1.1
0.9
1.2
1.7
1.8
1.2
0
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14*
Quality issues raised by USFDA and releasing alternative drugs to cope FDC bans remain
critical
The union health ministry banned 344 fixed dose combinations (FDC) in March 2016 under section 26 (A) of the drugs and
cosmetics act, 1940. A combination drug or FDC includes two or more active pharmaceutical ingredients (API) combined in
a single-dosage form, manufactured and distributed in fixed assets.
The Pharma sector is expected to report good growth for the fourth quarter of 2015-16 despite regulatory concerns raised by
USFDA and the recent ban on 344 fixed dose combinations imposed by the government. The price increase, volume growth
and new product innovation are likely to drive the domestic Pharma market.
According to various committees set up by the Health Ministry, India has a very large number of drug formulations, between
60,000 and 85,000. The authority given to state governments to clear FDCs has resulted in such a high number of
formulations becoming available in the market. The Health Ministry argues that such massive drug consumption due to a
www.jhaveritrade.com
Sector Update
The ministry of Commerce targets to exports USD25 billion worth of Pharmaceuticals in 2016.Indian drugs are exported
to more than 200 countries in the world, with the US as the key market.
Sector Update
Outlook
The size of the Indian Pharma is expected to touch US$ 48 billion by FY 2018 and US $55 billion by FY 2020 as against the
current size of US$18 billion. The government of India has released Pharma Vision 2020 aimed at making India a global
leader in end-to-end drug manufacture. Approval time for new facilities has been reduced to boost investments. The
government has taken many steps to reduce costs and bring down healthcare expenses. Speedy introduction of generic
drugs into the market has remained in focus and is expected to benefit the Indian pharmaceutical companies.The recent
sharp decline in stocks of Indian healthcare companies reflects investors concerns about the likely impact on earnings.
Although, the picture for Pharma companies remains good in the medium term, a lot depends on their ability to get the US
sales growth back on track. Failing that, the effect of various recent headwinds witnessed may have a magnified effect on
their earnings and stock prices.
Preferred Stocks
Ajanta Pharma Ltd.
APL is mainly into exports as well as domestic formulations. As of FY15, the exports: domestic formulation ratio was at
65:35. Domestic branded formulations constitute 32.7% of the total consolidated turnover (FY15). The focus on specialty
therapies and niche products led APL to post strong growth at a CAGR of 29.6% in FY11-15. APL is currently deriving
almost its entire export revenues from emerging regions like Africa (Franco Africa), Asia and LatAm having a presence in
more than 35 countries. Overall export formulations have grown at a CAGR of 31.4% in FY11-15 to ` 978.1 crore. The
company is entering into a stretched phase of capex ` 700-800 crore spread across two-three years) to bolster the domestic
business as well as exports franchise, especially the US.
Granules India Ltd.
The company intends to expand API capacities of Paracetamol, Metfomin and Guaifenecin by 25-30%, 3.5x and 2.7x,
respectively, which will support both its base and emerging businesses. In FY16, GIL has also increased its PFI capacity by
38-40% to 18,400MTPA. This debottlenecking is likely to support 16-18% PFI revenue CAGR over the next two years.The
company is coming up with a Greenfield multi-product API capacity at Vizag to support the growing need of internal
consumption and new filings. The company has invested heavily in R&D. With the acquisition of the Virginia facility in the
US, it now has two R&D centers - one in Vizag for developing normal ANDAs and one in Virginia for developing complex
ANDAs.
Company
FV (`)
CMP*(`)
P/E (x)
P/BV (x)
D/E Ratio
(x)
EBIDTA
(%)
ROCE
(%)
RONW
(%)
CFO
(` in Cr.)
Granules India
128
25.68
5.93
1.18
16.04
18.58
23.1
145.33
Ajanta Pharma
1498
35.19
15.68
0.14
34.42
55.98
43.2
279.42
www.jhaveritrade.com
CMP : ` 382
TGT : ` 498
ROI : 30%
Investment Rationale
Company Overview
Wonderla Holidays is one of the largest operators of amusement parks in India, which
owns and operates two parks under the brand name Wonderla, situated at Kochi ,
Bangalore, Hyderabad. In FY16, it had a cumulative annual footfall of . Company has
also developed the Wonderla Resort in Bangalore, a Three Star leisure resort, next to its
Financial Basics
10.00
10.41
37.11
5.51
0.6705
20.00
FV (`)
EPS (`) (TTM)
P/E (x) (TTM)
P/BV (x) (TTM)
BETA
RONW (%)
Investment rational
WHL is a key player in Indian Amusement Park Industry
WHL is the largest amusement park company in India with over a decade of successful
and profitable operations. It owns and operates three amusement parks under the
brand name Wonderla in Kochi, Bengaluru, Hyderabad and is coming up with a fourth
park in Chennai (to be operational by FY2019).
% Holding
WHLs theme parks are a value-for-money weekend entertainment option for people.
The ticket charges of `600-1,050 per person for entertainment of eight to nine hours is a
Foreign
12.38
Institutions
4.38
Promoters
70.99
Govt. Holding
0.00
9.01
provide WHL a great edge over the other theme and entertainment parks in the key
Non Promoter
Corp. Hold.
3.25
southern towns.
value proposition compared with the `200-500 spent on watching a movie in a multiplex
(entertainment for 2.5-3.0 hours).
Wonderlas Bangalore amusement park has been ranked No.1 in India while its Kochi
park has been ranked No.3. In Asia, Wonderla Bangalore is ranked No.7 and Wonderla
Valuations
WONDERLA is trading at ` 382.
We recommend Accumulate with
target price of ` 498 , valuing stock
30xFY18E EPS of `16.62.The stock
currently trades at 32.47x of FY16E,
27.93xof FY17E and 22.98x of
FY18E.
www.jhaveritrade.com
Company Analysis
BSE ID
538268
NSE Symbol
WONDERLA
Group
B
EQUITY (` in Cr.)
56.50
MKT.CAP(` in Cr.)
2182.90
Accumulate
Company Analysis
20.28
22.59
FY11
FY12
23.40
22.91
23.40
FY13
FY14
FY15
23.87
16.12
FY10
FY16
Attractions and Innovations- key growth driver for Amusement Park Operator
Visitor experience, higher footfalls, frequent visits and Per ticket revenue are largely depend on attraction offered by
operator in dry and water rides with innovation. WHL has more than decade experience as amusement park operator and
added various attractions time to time to attract new -age visitors, 2-3 attractions per year in various categories. Other big
operators in Banglore like Neeladri Amusement and Water Parks (45), Fun World (40) have lesser attractions as compared
to WHL and very less park in Banglore where both water and land based rides available.
Various attractions launched during the years :
FY14 :
1) XDMAX : This is a virtual land ride where visitor experience 3D film with physical and environmental effects.
2) Mini Coco Cups : This is a ride is for kids which resembles like a set of cup and saucer.
3) Fire Brigade and Magic Plane for kids and family respectively.
FY15 :
Jungle Lagoon : The Company has started a new water attraction at Bangalore Park in FY15. Its an large jungle-themed
water attraction with special features like soft flooring, shallow water levels and five unique water slides and a large
water play tree-house to increase visitor experience.
FY16 :
1) RECOIL & KORNETO : The company has introduced RECOIL-Indias first ever reverse looping Roller Coaster ride
and a thrilling water slide attractionsKORNETO.
Location
Bangalore
Kochi
Hyderabad
59
62
43
20
23
18
39
39
25
Source: Company
www.jhaveritrade.com
Kochi
Hyderabad
81.75
93.17
49.50
39.20
28.75
27.00
42.55
64.42
22.50
Location
Source: Company
FY15
FY16
Kerala ( Kochi)
4.70%
5.90%
Karnataka ( Bangalore )
76.00%
73.40%
Tamilnadu
9.70%
11.20%
Andhra Pradesh
5.20%
5.60%
Others
4.30%
3.90%
Source: Company
www.jhaveritrade.com
Company Ananlysis
further development in existing place. Not only rides but peripheral infrastructure like resorts , restaurants and integrated
Company Analysis
The Indian amusement parks generate a major share 75-80% of their revenues from admission tickets which is significantly
higher as compared to international parks (50% total revenue). The remaining revenue comes from non ticket revenue and
this includes sale of products (F&B, Merchandising ) and other services like restaurant revenue, shop revenue and room
rental collections. Indian parks are heavily depended on admission fees.
Revenue Stream ( % of Total Revenue)
75-80%
35-37%
2%
35-37%
Entry Fees
Resort and Other Rentals
18-23%
50
25
40
34
32.39
13.53
22.51
18.54
20
26.56
30
20
32-35%
Source: Company
15
16.4
13.02
14.7
11.99
11.41
10
10
0
FY11
FY12
FY13
FY14
FY15
9MFY16
FY13
FY14
FY15
The non-ticketing revenue segment constitutes only ~20% of WHL s net revenue, as compared with 50% contribution in the
case of international amusement parks. This indicates the huge existing opportunity to grow the top line through this key
segment. There is strong possibility of generating more revenue streams.
WHL focuses on Integrated Parks to reduce this dependency on ticket revenue. Globally, integrated parks are in favor
where amusement parks include other services like resort, F&B centers , retail centers and merchandising offerings. In
India integrated parks are relatively new concept and slowly gaining traction in India.
In March 2012, WHL has established resort in its Bangalore As very few parks in India have accommodation facility, total
contribution from accommodation related revenues is only 2%. with rising disposable incomes, the in-park spending can
increase significantly over the next few years.
Accommodation-related revenues contribute a meagre ~4% to Wonderlas top line, compared with 35-37% contribution in
the revenue mix of a typical International Amusement Park. This displays the considerable value which can be potentially
tapped by positioning of Parks as a holiday destination.
www.jhaveritrade.com
Wonderla has already developed a three-star 84-room resort attached to its Bangalore park with the aim of creating Indias
first holiday destination park where families can come and relax, soak in the atmosphere, explore the park and city at a
leisurely pace and gain a truly complete and wholesome entertainment experience.
As net spend on entertainment and leisure increases, industry models from U.S. and Europe will be replicated in India.
Parks will market themselves as a holiday destination and the revenue mix will also align itself with international peers.
10
www.jhaveritrade.com
Company Analysis
Company Analysis
The Global Parks industry earned total revenue of $28 billion in 2012, which is expected to touch $29.5 billion by 2015.
There are more than 800 parks the world over, marking an attendance of over 600 million visitors each year. United States
is the largest market with more than 400 parks with an annual attendance of 300 million, followed by Europe with
approximately 250 parks and attracting 165 million visitors a year.
Region
US
Latin America
Canada
EMEA
Asia Pacific
50%
1%
2%
21%
26%
Type
No. of Parks
Annual Visitors
Large Parks
~ 15
Medium Parks
~ 50
Small Parks
~ 100
11
www.jhaveritrade.com
revenues (F&B and products sales) and an 8-10% increase in the annual ticket price, WHLs revenues are expected to grow
at a CAGR of 21% over FY2015-18. WHL has an operating profit margin of about 45%, which is better than that of some of
the mature international amusement park companies. The operating profit margin is more or less expected to remain stable
in the coming years (barring FY2017 when the OPM is expected to decline due to a higher operational spending towards the
Hyderabad park).
681.00
585.30
600.00
449.80
266
300
400.00
220
250
200.00
0.00
322
350
506.70
200
182
154
150
FY11
FY12
FY13
FY14
FY15
100
50
0
FY14
FY15
FY16E
FY17E
FY18E
Key Concern :
A significant decline in footfalls:
Any significant decline in footfalls due to environment hurdles (heavy rains, flooding affecting the infrastructure) or epidemic
breakthroughs (such as swine flu) will significantly affect the revenue growth of WHL.
Competition & Concentrated Revenue Stream :
Any competition which forces the company to reduce ticket prices will have an adverse impact on its financials.
12
www.jhaveritrade.com
Company Analysis
Company Analysis
Key Financials
Consolidated Key Financials
Equity Paid Up
Networth
Capital Employed
Total Debt
Gross Block (Excl. Reval. Res.)
Net Working Capital ( Incl. Def. Tax)
Current Assets ( Incl. Def. Tax)
Current Liabilities and Provisions ( Incl. Def. Tax)
Total Assets/Liabilities (excl Reval & W.off)
Gross Sales
Net Sales
Other Income
Value Of Output
Cost of Production
Selling Cost
PBIDT
PBDT
PBIT
PBT
PAT
Adjusted PAT
(`
in Cr )
FY 12
42
93.76
116.69
22.47
207.8
-17.04
5.95
22.99
139.68
113.13
113.13
1.39
113.23
54.12
0
57.14
56.01
45.58
44.45
30.04
30.04
FY 13
42
119.95
142.44
20.97
242.03
-14.79
9.6
24.38
166.82
137.85
137.85
1.52
137.97
67.57
11.99
64.33
61.87
52.49
50.03
33.59
33.58
FY 14
42
149.93
175.66
23.88
255.33
3.37
28.86
25.49
201.15
153.63
153.63
2.41
153.6
73.91
17.42
73.03
71.11
59.83
57.91
39.89
39.91
FY 15
56.5
356.44
373.61
15.13
269.52
-7.43
17.54
24.98
398.59
181.87
181.87
10.25
182.45
87.36
18.77
91.32
89.13
75.13
72.94
50.63
51.09
FY 12
0.24
0.16
0.6
69.19
491.87
1.1
40.34
50.51
40.29
44.27
36.46
FY 13
0.2
0.25
0.61
59.55
399.57
1.06
21.34
46.67
38.08
40.51
31.44
FY 14
0.17
0.61
0.62
49.96
370.19
0.97
31.16
47.54
38.95
37.62
29.56
FY 15
0.08
0.78
0.69
48.89
427.93
0.66
34.31
50.21
41.31
27.36
20
Ratio Analysis
Consolidated Key Financials
Debt-Equity Ratio (x)
Current Ratio (x)
Fixed Assets Ratio (x)
Inventory Ratio (x)
Debtors Ratio (x)
Total Asset Turnover Ratio (x)
Interest Cover Ratio (x)
PBIDTM (%)
APATM (%)
ROCE (%)
RONW (%)
13
www.jhaveritrade.com
DAYS
FREE TRIAL
Register Now
Conditions Apply*
08049336177
www.jhaveritrade.com | www.jetrade.in
STOCK
UPDATE
Sector Update
JK Cements Ltd.
Financial Basics
FV (`)
EPS (`)
Book Value (`)
P/E (x)
P/BV (x)
52 Week High (`)
52 Week Low (`)
Equity ( ` in Cr.)
MKT.CAP(` in Cr.)
10.00
17.63
231.23
35.39
2.70
745.00
425.00
69.93
4363.63
CMP: ` 565
Accumulate
New Developments
Demand is expected to remain good
After subdued demand and realization in the past few quarters, optimism started
setting in after the Budget. The government outlay to the infrastructure sector (40 per
cent of cement consumption) and the rural economy bodes well.
March is expected to remain good
Volume growth for many companies is expected to be higher in the March quarter, led
by demand pick-up in the north, west and central India, and price recovery. March
quarter results, while expected to be better than that of the December quarter, may not
fully reflect benefits of improved realizations as most price increases have come in
March. Average selling prices are seen down six-eight per cent year-on-year. This will
be eased by strong volume growth.
Foreign
1.47
Institutions
24.00
Non Prom.
1.61
Valuations
we maintain Accumulate rating with a revised target price of ` 650 /share (i.e. at 10x
Promoters
66.99
5.93
10.00
80.94
693.84
40.41
4.71
3454.90
2531.00
274.43
89769.25
18.43
Institutions
7.56
Non Prom.
62.77
Promoters
11.18
0.06
Target: ` 3850
CMP: ` 3172
Buy
New Development
UltraTech cementing a stronger future
UltraTechs definitive agreement with Jaiprakash Associates (JPA) to buy the latters
21.2-million tonnes per annum (mtpa) cement capacities is positive for Indias largest
cement producer. This is a slight change compared to the February memorandum of
understanding (MoU) between the two companies, wherein UltraTech was to acquire
22.4 mtpa capacities. The new deal now leaves out JPAs Karnataka-based 1.2-mtpa
plant, which is in close proximity to UltraTechs Malkhed plant.
Nevertheless, the enterprise value of ` 16,370 crore ($115 per tonne) is attractive and
lower than the $122 UltraTech had paid for JPAs Gujarat-based assets. The
acquisition, which is likely to be completed in 12-15 months, will take UltraTechs
overall capacity close to 90 mtpa.
Valuation
At the critical juncture demand recovery, UTCEMs strong focus on growth and cost
efficiency make it most predictable play. Impact of JPA deal would be contingent on
pace of recovery of the sector. It is a strong bet on the cycle upturn, and in our view, the
success in asset creation should overshadow any near-term concerns for long-term
investors. We value UTCEM at ` 3,850 (13x FY18E EBITDA; USD220/ton).
15
www.jhaveritrade.com
STOCK
UPDATE
FV (`)
EPS (`)
Book Value (`)
P/E (x)
P/BV (x)
52 Week High (`)
52 Week Low (`)
Equity ( ` in Cr.)
MKT.CAP(` in Cr.)
10.00
6.84
60.83
14.33
1.60
150.90
68.40
284.55
2788.58
21.39
Institutions
20.62
Non Prom.
8.68
Promoters
16.24
33.07
5.00
6.68
85.94
39.92
3.10
375.00
192.25
36.34
1938.01
Buy
CMP: ` 243
Buy
Foreign
21.39
Institutions
20.62
Valuations
We expect 16% revenue CAGR and 190bp EBITDA margin expansion over FY16-18,
Non Prom.
8.68
driving 39% PAT CAGR. We maintain Buy with a target price of ` 335 (37% upside).
Promoters
16.24
33.07
16
www.jhaveritrade.com
Sector Update
Financial Basics
Target: ` 135
CMP: ` 92
OPEN
FUNDAMENTAL
CALLS
Company
Current
Reco
Fundamental Stocks
52 Week
CMP*( ` )
High (`)
Low (`)
3M
6M
12M
Face
Value
(`)
Market
P/BV
Cap
(` in Cr) (x)
P/E
(x)
Dividend Yield
%
Automobile
Ashok Leyland
Hold
106
M&M
Hold
1327
Maruti Suzuki
Hold
3728
112.90
63.80
22%
12% 57%
30152
8.64 33.96
0.42
13%
82388
3.19 28.76
0.90
5%
112614
4.63 35.34
0.67
-12% -18%
147091
1.74 12.51
1.97
6%
Banks
ICICI Bank
Buy
253
338.00
180.75
7%
Bank of Baroda
Hold
158
216.30
109.35
22%
-9%
-9%
36371
0.83
9.65
1.95
Hold
95
105.55
77.80
21%
7%
-1%
5695
1.95 13.45
1.15
DCB Bank
Hold
95
150.90
68.40
30%
8%
-19%
10
2699
1.55 13.87
0.00
Capital Goods
Havells India
Hold
343
354.00
235.30
21408
11.77 61.42
0.88
TD Power Sys.
Buy
238
350.95
10
791
1.60 41.17
1.11
Inox Wind
Buy
271
482.50
10
6013
4.32 16.67
0.00
Carborundum Uni.
Buy
192
211.00
150.10
3620
3.33 27.33
0.65
Thermax
Hold
768
1148.00 715.00
9153
4.26 46.31
0.91
-4%
10
4264
2.64 34.58
0.66
10
89909
4.27 40.48
0.29
12%
9%
7%
Cement
J K Cements
Hold
610
UltraTech Cem.
Hold
3276
745.00
425.00
20%
-7%
Finance
Dewan Hsg. Fin.
Buy
200
267.85
140.30
6%
-15% -11%
10
5830
1.23
8.31
1.38
Hold
655
785.00
551.00
4%
-5%
10
4094
4.62 28.70
0.23
Buy
39
60.60
29.70
10
2215
1.30
6.19
2.54
8%
Infrastructure
Larsen & Toubro
Buy
1266
117924
2.88 26.66
1.28
Adani Ports
Buy
232
374.80
169.15
-26% -27%
48005
4.46 18.37
0.47
Ashoka Buildcon
Buy
142
221.00
2662
1.43 25.72
0.91
10
3153
3.41 23.90
2.41
6%
Logistics
-6% -15% -19%
Gateway Distr.
Hold
290
399.70
205.80
Allcargo Logist.
Hold
158
217.75
0%
3976
2.08 15.02
0.63
VRL Logistics
Buy
401
479.00
261.05
-2%
NA
10
3654
5.69 34.38
0.94
1%
17
www.jhaveritrade.com
OPEN
FUNDAMENTAL
CALLS
Fundamental Stocks
Company
Current
Reco
52 Week
CMP*( ` )
Low (`)
3M
6M
12M
Market
P/BV
Cap
(` in Cr) (x)
P/E
(x)
Dividend Yield
%
Pharmaceuticals
Torrent Pharma.
Buy
1423
1718.40 1135.00
2%
-10% 17%
24075
9.67
15.15
0.79
Sun Pharma.Inds.
Hold
809
1010.00 704.00
0%
-9% -15%
194668
7.60
44.22
0.37
Granules India
Buy
131
164.40
75.00
7%
-11% 45%
2842
6.09
26.39
0.36
14% 15%
1965
5.83
30.68
0.00
2137
1.71
21.28
0.60
Realty
Ahluwalia Contr.
J Kumar Infra
Buy
293
320.00
188.20
Hold
282
448.50
233.65
7%
Textiles
436.50
172.00
5%
4%
95%
10
801
2.58
19.08
0.82
1348
1498.85 899.00
19%
4%
34%
10
7737
3.41
20.66
0.74
Buy
105
163.15
-17% -4%
NA
10
414
2.42
8.88
0.09
Buy
871
1149.00 706.05
-4%
0%
10
512
1.58
10.63
1.61
2%
1217
1.42
15.80
0.87
25% 31%
1119
5.69
18.99
0.78
Garware-Wall Rop
Buy
366
SRF
Buy
AYM Syntex
Ambika Cotton
85.50
8%
Miscellaneous
Radico Khaitan
Hold
92
130.70
78.70
-18% -8%
Buy
141
156.20
88.00
-4%
Bharat Forge
Buy
794
1331.75 720.00
18491
5.37
26.58
0.94
Omkar Spl.Chem.
Hold
184
249.90
138.35
10
379
2.25
11.84
0.82
Sadbhav Engg.
Buy
286
370.00
197.15
-7%
-6%
-7%
4899
3.19
34.96
0.25
Eveready Inds.
Hold
257
375.00
192.25
2%
-14% -14%
1868
2.99
38.47
0.00
Inox Leisure
Buy
208
275.90
145.15
10
2005
2.83
32.95
0.00
Prabhat Dairy
Buy
118
169.00
71.00
2%
-17% NA
10
1153
1.80
49.39
0.04
Infinite Comp
Hold
216
275.80
122.20
0%
18% -19%
10
837
1.06
8.29
0.00
Liberty Shoes
Buy
174
283.25
125.00
4%
-17% -30%
10
297
2.04
17.47
0.86
Hold
317
350.00
165.00
9%
25% 47%
1891
4.20
23.85
0.47
CARE
Hold
1056
1619.50 883.00
10
3105
8.09
41.40
7.38
Century Ply.
Buy
179
225.00
135.65
9%
-2% -18%
3967
10.23 28.48
1.12
Hitech Plast
Hold
165
221.40
80.75
-3%
59% 51%
10
283
2.22
26.63
0.48
Mold-Tek Pack.
Buy
150
166.75
81.28
7%
23% 42%
416
3.29
19.83
1.33
Torrent Power
Buy
236
252.70
136.75
10
11326
1.73
11.60
0.63
HPCL
Hold
861
990.95
556.05
9%
8%
38%
10
29141
2.14
22.30
2.85
Skipper
Buy
149
219.90
117.00
-12% -3%
NA
1520
4.47
17.04
0.88
(*CMP as on 25/04/2016)
18
www.jhaveritrade.com
High (`)
Face
Value
(`)
Scheme Name
NAV*
NAV*
1 Year
Launch
(Div)
(growth)
(%)
Date
Top Equity Diversified Funds
3 Year
(%)
5 Year
(%)
Since Inc
9.64
9.64
-4.65
NA
NA
-3.20
16-May-00
23.59
149.41
-0.24
20.33
11.61
18.50
5-Feb-03
33.44
169.69
-2.18
15.76
10.54
22.21
11-Sep-09
18.46
22.82
-0.91
22.63
14.20
13.31
4-Apr-08
16.37
31.95
-2.47
21.52
14.15
15.54
29-Jul-15
9.99
9.99
NA
NA
NA
-0.13
27-May-99
22.94
108.97
-0.34
16.96
10.42
15.17
8-Oct-95
71.04
167.46
-2.23
20.64
15.13
16.44
0.01
18.54
12.36
20.95
0.94
21.56
13.74
13.9
4-Mar-15
10-Feb-95
133.37
564.35
7-Feb-11
17.24
19.67
12.91
14.71
-7.43
NA
NA
17.62
30-Mar-07
20.58
26.54
0.96
30.15
18.49
11.37
9-Jul-10
22.02
30.97
3.77
34.14
23.07
21.60
17-Mar-08
31.14
34.34
-4.43
28.40
19.39
16.47
31.98
97.86
-6.09
30.80
18.06
11.02
1-Jul-94
31-Mar-96
60.70
12.13
1.95
22.29
14.04
19.83
26-Dec-08
13.36
37.06
-9.45
20.49
13.1
19.61
10.99
10.99
2.21
NA
NA
7.94
29-Dec-06
17.61
34.70
-2.50
22.53
14.63
14.30
29-Dec-09
19.56
29.91
-4.73
27.60
19.26
18.97
Conservative Funds
Franklin India Dynamic Pe Ratio Fund
31-Oct-03
37.19
63.28
2.47
11.93
9.28
15.94
31-Oct-02
20.32
180.80
-6.48
17.85
10.70
23.97
16-Dec-10
15.13
16.72
0.48
15.42
11.02
10.10
-3.12
15.27
10.72
9.15
-1.22
NA
NA
4.12
04-Oct-07
17.66
21.13
10-Oct-14
10.44
10.63
NAV
(Growth)
YTM (%)
3 Months (%)
6 Months (%)
1 year (%)
27-Apr-11
15.39
8.13
14.13
6.87
7.90
1-Dec-08
17.96
7.71
9.02
4.25
5.86
12-Jun-09
17.09
8.59
15.62
8.33
9.21
15-Nov-04
20.30
8.37
14.24
6.36
6.87
*NAV as on 18/04/2016
19
www.jhaveritrade.com
360.00
360.25
359.91
1-Apr-16
8-Apr-16
358.00
356.00
355.94
351.48
352.00
351.83
350.86
350.36
349.15
350.00
348.00
355.54
353.4
354.00
347.20
347.56
346.78
346.00
344.00
342.00
15-Apr-16
35704
35794
35704
35794
33068
32690
32209
35000
30937
33961
29796
28714
30000
27790
27280
22719
20739
21075
22297
20014
21408
21720
21272
23143
22263
21998
15000
23884
20000
21274
25000
10000
Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16
12
9.81
10
8
6.26
4.24
4.34
3.01
2.48
3.84
1.99
2.51
0
-2
-1.34 -1.53
-3.2
-4
Feb-15
Mar-15
Apr-15
May-15
Jun-15
Jul-15
Aug-15
20
Sep-15
Oct-15
Nov-15
Dec-15 Jan-16
Feb-16
www.jhaveritrade.com
359.75
6.10
5.79
5.37
5.11
6.32
5.74
6.32
5.14
5.17
4.37
4.35
Sep-15
6 5.86
5
Aug-15
5.91
5.53
3
2
Feb-16
Jan-16
Dec-15
Nov-15
Oct-15
Jul-15
Jun-15
May-15
Apr-15
Mar-15
Feb-15
Dec-14
Jan-15
-0.91
-0.85
-0.73
-2 -2.17
-2.33
-3
-1.99
-2.13
-2.2
-2.43
-4
-3.79
-3.81
-5
-4.54
-4.85
-6
Feb-15
Mar-15
Apr-15
May-15
Jun-15
Jul-15
Aug-15
Sep-15
250
Oct-15
Nov-15
Dec-15
211
200
150
117 115
100
86
120
67
53
50
123
103
85
63
105
69
0
-50
-100
-58
-14
-33
-65
-28
-71
-122
-150
-200
Jul-15
-169
Aug-15
Sep-15
-17
-55
Oct-15
21
Nov-15 Dec-15
Jan-16
-157
Feb-16
Mar-16
Apr-16
www.jhaveritrade.com
Basic Difference
Purpose of DVR
Hostile Takeover
A takeover which goes against the wishes of the target company's management and board of directors.
DVR prevents the major harm of hostile take over. As more number of shares are available publicly, there is a strong
possibility of hostile take over.
As the voting right is less, so it can prevent hostile takeover.
Dilution of Voting Right
As in ordinary shares inventor can cast as many as vote, the shares posses.
It will difficult for the company to take decision if there is difference of opinion by various shareholders by there voting
right that can effect the growth of the company.
DVR prevent dilution of Voting Right.
Strategic Investor and Fund Raising
Many big investors want to invest a huge amount of money for capital appreciation and want become a part of companies
strategic decision. These investors are not interested in control of the company.
DVR will help them to fulfill there purpose. Through this company can raise huge amount of funds.
22
www.jhaveritrade.com
JSL Classroom
equity share holders can give same number of vote as the number of shares hold and take the part in the decision making
JSL Classroom
Disadvantages
Conclusion
The shares with inferior voting rights may be beneficial for the retail investors as these shares would not only be issued at a
discount to the prevailing market price of the normal equity shares but also provide better dividend yield. So the investors
interested in high divided and can wait for long time for capital appreciation can go for DVRS.
23
www.jhaveritrade.com
Stock Selection Methodology : Based on various fundamental parameters and valuation check along with certain themes
like Cyclical, Bottom Up, Sector specific, Policy Initiative/ push , Evergreen.
Key Risks : Macro economic / political condition and systematic risk, corporate performance risk
Stock
Weights
Weights
Sector
Suggestions
Price**
CMP*
Target
Potential Upside
Maruti Suzuki
Automobile
7%
Accumulate
4639
3734
5200
39%
KEC International
Capital Goods
5%
Accumulate
157
126
180
43%
Bharat Forge
8%
Accumulate
888
796
1200
51%
Ultratech Cement
Cement
7%
Buy
2824
3277
3400
4%
8%
Buy
236
199
368
85%
Pharma
7%
Accumulate
815
808
1041
29%
Inox Wind
Power
8%
Buy
360
270
488
81%
Torrent Power
Power
8%
Buy
181
235
280
0%
PSU Bank
7%
Accumulate
228
197
325
65%
Axis Bank
Public Bank
7%
Accumulate
450
470
620
32%
VRL Logistics
Logistics
5%
Buy
432
399
457
15%
Torrent Pharma
Pharma
8%
Buy
1479
1426
1840
29%
Ashoka Buidcon
Infrastructure
5%
Buy
200
142
205
44%
Ahluwali Contracts
Infrastructure
Consumer
Non-Durable
5%
Buy
282
291
368
26%
5%
Accumulate
300
255
287
13%
Everday Industries
Particulars
-6.34%
Nifty
-1.84%
-15.43%
Sensex
-1.36%
-9.34%
-2.75%
Notes : *CMP as on 25/04/2016., Price ** on recommendation and as on 01/01/2016 , Return since inception indicates
from 1st Jan -2016
24
www.jhaveritrade.com
Ideal Portfolio
and growth oriented mid cap companies. This will help to generate meaningful wealth for Investors from Equity Market.
Ideal Portfolio
Objective : The aim is to generate long term capital appreciation from a portfolio that is not part of the leading stocks by
market capitalization. The aim is to include and invests in companies that have immense growth potential as they are
operating on a smaller base.
Stock Selection Methodology : Based on various valuation parameters and finding out early stage companies
based on sound business model and available at cheap valuation
Key Risks :
Small-cap stocks are not tracked closely by market/ equity analysts and that is why the real value of good small-cap stocks
can remain undiscovered for long. This makes investing in them risky. The risk associated with large cap funds also
associated with small cap ( see last page). Small companies are relatively weak in terms of governance, dividend policies
and professionalism of the board. This makes them risky.
Stock
Sector
Weights
Suggestions
CMP*
Target
Potential Upside
AYM Syntex
Textile
10%
Accumulate
106
223
110%
Good Year
Tyre
10%
Accumulate
507
868
71%
KPR Mills
Textile
10%
Accumulate
857
1120
31%
KRBL
Food Processing
10%
Accumulate
215
360
67%
Textile
10%
Accumulate
365
550
51%
Smartlink Network
IT- Hardware
10%
Accumulate
103
156
51%
MPS
Printing
10%
Accumulate
689
1150
67%
MT Educare
Education
10%
Accumulate
173
220
27%
Capital Goods
10%
Accumulate
607
890
47%
Textile
10%
Accumulate
871
1149
32%
16%
Pharmaceuticals
15%
Banks
14%
Infrastructure
10%
Textile
30%
Computer - Hardware
10%
Education
10%
8%
Food Processing
10%
8%
Pharmaceuticals
10%
Automobile
7%
10%
Cement
7%
Capital Goods
5%
Retail
10%
Consumer Non-Durable
5%
Tyre
10%
Logistics
5%
25
www.jhaveritrade.com
SRTRANSFIN
ABAN
ICICI BANK
BANKINDIA
We have observed that stock has made lows in February and then
bounced back to test its 21 Day moving average at 100 Rs levels. But
again stock given negative crossover in Stochastics and its ADX is
moving continuously above 40 levels suggests stock is weak and
every rise should be used to positional sell the stock.
26
www.jhaveritrade.com
USD INR
We had said last month that Doji is formed and range for month is 9498 for April month. On Monthly Chart, Stochastics was oversold last
month and the pair has made low of 93.70 and bounced back from
93.70 to 98 levels. Moreover, Pair has been trading above its 50 day
moving average 94 and below is 21 Day moving average at 97.95,
which shows that near to medium term trend is up. The short term
momentum is up and can go to 99.50-100 levels.
EUR INR
JPY INR
Pair has crossed 61.80 levels which was strong resistance till last
month on daily charts. The pair has given close above that level on
monthly closing basis. On weekly chart JPY INR pair is showing
strength and has strong support at 58.00 levels and on monthly chart
JPY INR pair has strong support at 56.00 level. The upside target
remains 64.5-65 levels. The Pair is trading above its 21 Day Moving
average (56.74) and 50 Day Moving average (57.42) levels.
27
www.jhaveritrade.com
Bank Nifty
The index opened at 16099, made high of 17029, made a low of 15440 and closed the month at 16795. Last month we had
said that Banknifty should face stiff resistance at 16300-16400 zone where supply is expected to come and if Banknifty
manages to close above this zone on weekly closing basis, then it might head towards 17000-17500 levels. Banknifty made
high of 17029 level in April. Banknifty is in strong uptrend and buy on dips is recommended with positional stop loss of
16000. The crucial resistance remains at 17150 levels But Stochastics indicator is suggesting positive momentum to
continue.If Banknifty manages to close above that for 2 consecutive days, then the next target remains 18000 levels.
28
www.jhaveritrade.com
The index opened at 7718, made a high of 7992, made a low of 7516 and closed the month at 7849. Last month we had
clearly mentioned that Nifty is in Uptrend above 7550 but it should face stiff resistance at 7700-7780 zone where supply is
expected to come and if Nifty manages to close above this zone on weekly closing basis, then nifty might head towards 7930
levels. The next crucial resistance is at 7970-8000 levels which is 50% retracement of fall from high of 9119 in Mar 2015 to
low of 6825 in Feb 2016. If nifty manages to close above this zone for consecutively 2 days then Nifty will be heading towards
8250 levels. Nifty is in uptrend and has strong support at 7700 levels. Stochastics indicator is suggesting positive
momentum to continue. We advise buy on dips strategy in largecaps with positional stop loss of 7700.
29
www.jhaveritrade.com
Balanced Funds
Balanced funds are a combination of equity and debt. Equity oriented Balanced Funds maintain at least 65% of exposure in
perspective, the long term capital gains tax (Investments period of more than one year) is free for this category of Balanced
Funds. The dividends earned on these funds are also tax free.
There are many types of Hybrid or Balanced Funds like MIPs, Asset Allocation Funds and Capital Protection Funds. But
funds which are equity oriented with 65%-80% exposure in equity market but with some debt portfolio as well are called
Balanced Funds. They basically try to mix the benefits of both the worlds so as to provide a one-for-all solution to its
customers. It is quite a good choice for someone who wants to invest in equity market but is not too keen in taking risk on the
entire portfolio. Balanced Funds usually have a good large cap stock portfolio with a mixture of good quality debt securities.
27
30
www.jhaveritrade.com
Mutual Fund
domestic equities and can invest upto 35% in debt securities depending upon the fund objective. In fact from the taxation
Balanced Funds
Mutual Funds
Year
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
Balanced
Funds Return
25.54
35.03
-31.94
52.73
14.08
-13.41
23.33
4.77
34.59
3.16
Large Cap
Funds Return
39.24
57.63
-53.63
77.2
16.7
-24.48
28.74
4.26
40.45
-0.86
Sensex Open
9,422.49
13,827.77 20,325.27
9,720.55
Sensex Close
13786.91
20,286.99
9,647.31
17464.81
Sensex Difference
Increase
Increase
Decrease
Increase
Increase
Decrease
Increase
Increase
Increase
Decrease
From the above example, you can see that the balanced funds have sometimes done better than large caps and sometimes
not. To evaluate the data, let us consider the years 2006, 2007, 2009, 2010, 2012 and 2014. In these 6 years, out of the 10
years, the Large Cap Equity Funds have given better return than that of Balanced Funds as there has been an upward rise in
the Sensex in these years. However, whenever the market fell in the year 2008, 2011 and 2015 and in a volatile year like
2013 the balanced funds as a category has fallen less and thus we can conclude that these gave better return than that of
large cap funds as a category.
Conclusion
If you are a retail investor and wish to opt for a fund wherein you would like to invest and then forget the same for a good long
time, then Balanced Funds can be one of the best suited solutions for your need. Balanced Funds are quite a good option as
it provides exposure to both equity and debt securities but the same cannot be used as a comparison tool against pure
equity fund returns. Balanced Funds are tax efficient as the long term capital gains are tax free and also the dividend
received from balanced funds are also tax free.
You thus get to have the best of both the worlds - good exposure to equity with a 65%, equity tax advantage and yet a hedge
towards the market volatility by having a 35% of debt securities.
26
31
www.jhaveritrade.com
Date
Sun May 1
Country/Event
Manufacturing PMI
Non-Manufacturing PMI
Spanish Manufacturing PMI
ISM Manufacturing PMI
Construction Spending m/m
ISM Manufacturing Prices
Caixin Manufacturing PMI
EU Economic Forecasts
PPI m/m
IBD/TIPP Economic Optimism
Spanish Unemployment Change
Spanish Services PMI
ADP Non-Farm Employment Change
Prelim Nonfarm Productivity q/q
Prelim Unit Labor Costs q/q
Trade Balance
ISM Non-Manufacturing PMI
Factory Orders m/m
Crude Oil Inventories
Caixin Services PMI
Unemployment Claims
Natural Gas Storage
French Gov Budget Balance
French Trade Balance
Average Hourly Earnings m/m
Non-Farm Employment Change
Unemployment Rate
German Factory Orders m/m
French Industrial Production m/m
Sentix Investor Confidence
Labor Market Conditions Index m/m
CPI y/y
PPI y/y
German Industrial Production m/m
German Trade Balance
Italian Industrial Production m/m
NFIB Small Business Index
Wholesale Inventories m/m
Crude Oil Inventories
10-y Bond Auction
French Prelim Non-Farm Payrolls q/q
M2 Money Supply y/y
New Loans
Industrial Production m/m
Unemployment Claims
Import Prices m/m
JOLTS Job Openings
Natural Gas Storage
German Prelim GDP q/q
Flash GDP q/q
Core Retail Sales m/m
PPI m/m
Retail Sales m/m
Core PPI m/m
Prelim UoM Consumer Sentiment
Industrial Production y/y
Fixed Asset Investment ytd/y
French Final CPI m/m
Empire State Manufacturing Index
NAHB Housing Market Index
Date
Tue May 17
Wed May 18
Thu May 19
Fri May 20
Mon May 23
Tue May 24
Wed May 25
Thu May 26
Fri May 27
Mon May 30
Tue May 31
Country/Event
TIC Long-Term Purchases
Italian Trade Balance
Trade Balance
Building Permits
CPI m/m
Core CPI m/m
Housing Starts
Capacity Utilization Rate
Industrial Production m/m
German WPI m/m
Final CPI y/y
Crude Oil Inventories
FOMC Meeting Minutes
Current Account
Italian Retail Sales m/m
ECB Monetary Policy Meeting Accounts
Philly Fed Manufacturing Index
Unemployment Claims
German PPI m/m
Existing Home Sales
French Flash Manufacturing PMI
French Flash Services PMI
German Flash Manufacturing PMI
German Flash Services PMI
Flash Manufacturing PMI
Flash Services PMI
Flash Manufacturing PMI
Flash Services PMI
German Final GDP q/q
German ZEW Economic Sentiment
ZEW Economic Sentiment
Core Durable Goods Orders m/m
Durable Goods Orders m/m
CB Leading Index m/m
Belgian NBB Business Climate
New Home Sales
GfK German Consumer Climate
German Ifo Business Climate
Goods Trade Balance
HPI m/m
Crude Oil Inventories
ECB Financial Stability Review
Unemployment Claims
Pending Home Sales m/m
Natural Gas Storage
French Consumer Spending m/m
Italian Monthly Unemployment Rate
Italian Prelim CPI m/m
Prelim GDP q/q
Revised UoM Consumer Sentiment
German Prelim CPI m/m
Spanish Flash CPI y/y
German Retail Sales m/m
M3 Money Supply y/y
CPI Flash Estimate y/y
Core CPI Flash Estimate y/y
Core PCE Price Index m/m
Personal Spending m/m
Chicago PMI
CB Consumer Confidence
DISCLAIMER : Trading and Investment decision taken on your consultation are solely at the discretion of the traders/investors.We are not liable for any loss, which occur as a result of our recommendations. This document has
been prepared on the of publicly available information, internally developed data and other sources believed to be reliable.
NSE:INB/F/E 230823233 BSE: INB/F 010823236 NSDL: IN-DP-NSDL-166-2000, MCX-SX: INE 26082333 AMFI ARN 3524 MCX: TM 29040 / FMC REG NO. MCS / TC / CORP / 0963 MCDEX: TM 00749 / FMC REG NO.
NCDEX / TCM / CORP / 0736 / NSEL TM 10110* Note: Dealing in Commodity Segment through its group company Jhaveri Credits & capital Ltd.
Distributors for IPOs & Mutual Funds. Past performance is not a measure for future returns.